Authors
Yurui Zhang, Yitong Li, Yudi Wang, Yucui Dong
Published in
Biochimica et biophysica acta. Reviews on cancer. Pages 189753. Nov 18, 2026. Epub Nov 18, 2026.
Abstract
In adults, glioblastoma (GBM) is the most common malignant primary tumor of the brain and other central nervous system sites and is linked to older age and generally poor outcomes. Chronological aging and cellular senescence are distinct processes, but both can reshape the GBM tumor microenvironment (TME). Following radiotherapy or chemotherapy, both malignant and non-malignant cells may enter a senescence-associated state. When these cells persist, their senescence-associated secretory phenotype (SASP) may reshape the extracellular matrix (ECM), maintain inflammation, and support residual tumor-cell survival, stem-like plasticity, and treatment resistance. Age-associated or senescence-associated changes also occur in immune and stromal compartments, although bona fide cellular senescence has not been established uniformly across T cells, macrophages, neutrophils, and fibroblast-associated populations. This review focuses on how cellular senescence, particularly therapy-induced senescence, reshapes the GBM microenvironment through SASP signaling and how these effects intersect with age-associated remodeling of tumor, stromal, extracellular-matrix, and immune compartments. We also discuss senescence-inducing therapies, senolytic and SASP-directed strategies, and the major challenges to their clinical translation. Current evidence supports biomarker-guided targeting of defined post-treatment SASP pathways and temporally controlled senolytic intervention as promising translational directions, while blood-brain barrier penetration, senescence heterogeneity, and off-target effects in normal neural tissue remain major challenges.
PMID:
43051604
Bibliographic data and abstract were imported from PubMed on 19 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 5
- Comments 0